The C. elegans germ line presents several biological features similar to those of human cancer stem cells (CSCs). First, the germ line contains a small population of self-renewing cells represented as germ stem cells. Second, the distal tip cell (DTC) provides a niche that expresses the LAG-2 proliferative signal to the germ stem cell GLP-1/Notch receptor ortholog. Further, the C. elegans
glp-1 mutant
glp-1(
ar202) exhibits constitutive activity of GLP-1/Notch signaling, generating a germline tumor with a phenotype highly reminiscent of the behavior of human cancers. This germ stem cell population is resistant to apoptotic stimuli and has a high DNA repair capacity, resulting in resistance to the lethal effects of ionizing radiation (IR). The goal of this study is to identify and target genes that are responsible for the radiation resistance in the
glp-1(
ar202) CSC tumor model. In preliminary studies, we have developed an optimized readout system to assess IR-induced
glp-1(
ar202) tumor response, as a baseline for mechanistic studies to assess the role of DNA damage repair enzymes in the radioresistance phenotype. We also confirmed that
glp-1(
ar202) CSC death by IR is not through apoptosis, but rather appears akin to the mitotic death conferred by radiation treatment of most mammalian solid tumors. Further, we targeted
rad-51 and
mre-11, genes that regulate homologous recombination (HR) and found that their silencing by RNAi significantly increased sensitivity of the germline tumor to IR, reducing the IR dose required to eradicate
glp-1(
ar202) tumors by 50%. We are also using immunostaining of DNA repair foci to quantitatively study the role of HR and other DNA repair pathways in the
glp-1(
ar202)tumor model response to IR. We anticipate that some gene products on these pathways will have a major impact on radiation sensitivity, and may lead to discovery of new targets for enhancing radiotherapy sensitivity in human cancer.